Postoperative complications in rheumatic disease patients undergoing arthroscopy on immunosuppression.
| Autor: | Vasavada K; Division of Sports Medicine, Department of Orthopaedic Surgery, New York University Langone Orthopedic Center, New York, NY, USA., Lin CC; Department of Orthopaedic Surgery, New York University Langone Orthopedic Center, New York, NY, USA., Jazrawi LM; Division of Sports Medicine, Department of Orthopaedic Surgery, New York University Langone Orthopedic Center, New York, NY, USA., Samuels J; Clinical Initiatives, Division of Rheumatology, NYU Langone Health, New York, NY, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Physician and sportsmedicine [Phys Sportsmed] 2024 Oct; Vol. 52 (5), pp. 507-512. Date of Electronic Publication: 2024 Mar 11. |
| DOI: | 10.1080/00913847.2024.2324363 |
| Abstrakt: | Background: There are currently no guidelines on peri-arthroscopic management of immunosuppressive (IS) treatment in rheumatic disease patients. Purpose: The purpose of this study is to characterize the rheumatic disease patient population undergoing arthroscopy, compare the incidence of postoperative complications among patients who either remained on IS perioperatively, held IS perioperatively or were not on IS at baseline, and compare the incidence of postoperative complications by rheumatic disease type, medication type, and procedure. Methods: We conducted a retrospective review of all arthroscopic sports medicine surgeries in patients with a rheumatic disease diagnosis at our institution over an 11-year period. Patients on IS at baseline were grouped into those who remained on IS perioperatively or held all IS before the date of their surgery. These two groups were compared to patients who were not on IS at baseline. Incidence of postoperative complications was calculated for the three cohorts and by medication class, rheumatic disease type, and procedure risk. Analysis of variance (ANOVA), chi-squared, and Fisher's exact tests were used to determine the statistical significance of between-group differences in postoperative complication incidence. Results: We identified 1,316 rheumatic disease patients undergoing arthroscopy, with 214 of them taking IS medications at baseline. In total, 8.4% ( n = 110) remained on IS perioperatively, 7.9% ( n = 104) held IS perioperatively, and 83.7% ( n = 1102) were not on IS at baseline. In all cohorts, seven patients experienced postoperative complications; six of whom experienced infections. Two (1.82%) occurred in patients remaining on IS perioperatively, zero infections occured in patients who held all IS, and four (0.36%) occured in patients who were not on any IS at baseline. There was no statistically significant difference in postoperative infections or complication rates among the three cohorts or further subgroups. Conclusion: The risk of postoperative complications including infectious, major, and minor complications in patients on IS at the time of arthroscopy is low and acceptable. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|